-
公开(公告)号:US07109214B2
公开(公告)日:2006-09-19
申请号:US10993545
申请日:2004-11-19
申请人: Oswald Zimmer , Michael Haurand , Klaus Schiene , Clemens Gillen , Johannes Schneider , Gregor Bahrenberg
发明人: Oswald Zimmer , Michael Haurand , Klaus Schiene , Clemens Gillen , Johannes Schneider , Gregor Bahrenberg
IPC分类号: A01N43/40
CPC分类号: C07C317/32 , C07C2601/10 , C07D317/56
摘要: The present invention relates to substituted cyclopentene compounds of the general formula I, to a process for the production thereof, to pharmaceutical preparations containing these compounds and to the use thereof for the production of pharmaceutical preparations.
摘要翻译: 本发明涉及通式I的取代环戊烯化合物,其制备方法,含有这些化合物的药物制剂及其用于生产药物制剂的用途。
-
公开(公告)号:US20060183700A1
公开(公告)日:2006-08-17
申请号:US10513490
申请日:2003-05-06
申请人: Axel Vater , Christian Maasch , Florian Jarosch , Mathias Bell , Steffen Helmling , Bernd Eschgfaller , Elisabeth Moyroud , Sandra Stark , Sven Klussmann , Thorsten Ruppert , Gregor Bahrenberg , Clemens Gillen , Klaus Schiene
发明人: Axel Vater , Christian Maasch , Florian Jarosch , Mathias Bell , Steffen Helmling , Bernd Eschgfaller , Elisabeth Moyroud , Sandra Stark , Sven Klussmann , Thorsten Ruppert , Gregor Bahrenberg , Clemens Gillen , Klaus Schiene
CPC分类号: C12N15/115
摘要: The invention relates to an antagonist for CGRP and amylin, whereby the antagonist is a nucleic acid and said nucleic acid binds to CGRP or amylin. Said nucleic acid preferably comprises an L-nucleotide.
摘要翻译: 本发明涉及CGRP和胰岛淀粉样多肽的拮抗剂,其中拮抗剂是核酸,所述核酸与CGRP或胰岛淀粉样多肽结合。 所述核酸优选包含L-核苷酸。
-
公开(公告)号:US20050277687A1
公开(公告)日:2005-12-15
申请号:US11133190
申请日:2005-05-20
IPC分类号: A61K31/135 , A61K31/341 , A61K31/415 , A61P29/00 , A61K31/137
CPC分类号: A61K31/635 , A61K31/135 , A61K31/137 , A61K31/341 , A61K31/365 , A61K31/415 , A61K2300/00
摘要: Combinations of certain analgesics with certain COX-II inhibitors, related pharmaceutical compositions, including advantageous galenical forms containing these combinations, and to the use thereof in methods of treatment, in particular for the treatment of pain.
摘要翻译: 某些止痛剂与某些COX-II抑制剂的组合,相关的药物组合物,包括含有这些组合的有利的盖仑制剂,以及其在治疗方法中的用途,特别是用于治疗疼痛。
-
-